VCF1
Protein VCF1
Also known as: FAM104A, FLJ14775, VCF1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969W3
- Gene
- VCF1
- Ensembl
- ENSG00000133193
- Chromosome
- 17
- Canonical length
- 186 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
No narrative summary is available for VCF1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
186 residues, UniProt reviewed canonical sequence.
>Q969W3|VCF1
1 MGGRGADAGS SGGTGPTEGY SPPAASTRAA ARAKARGGGR GGRRNTTPSV PSLRGAAPRS
61 FHPPAAMSER LRPRKRRRNG NEEDNHLPPQ TKRSSRNPVF QDSWDTESSG SDSGGSSSSS
121 SSSINSPDRA SGPEGSLSQT MAGSSPNTPQ PVPEQSALCQ GLYFHINQTL REAHFHSLQH
181 RGRPLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VCF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 93 nTPM
Expression across tissuesHPA
Tissue
- testis: 93 nTPM
- bone marrow: 42 nTPM
- skin: 20 nTPM
- thymus: 20 nTPM
- stomach: 19 nTPM
- lymph node: 17 nTPM
Single-cell type
- late spermatids: 2,602 nCPM
- early spermatids: 1,447 nCPM
- late primary spermatocytes: 786 nCPM
- syncytiotrophoblasts: 416 nCPM
- cytotrophoblasts: 156 nCPM
- platelets: 143 nCPM
Immune cell
- T-reg: 93 nTPM
- eosinophil: 64 nTPM
- basophil: 64 nTPM
- total PBMC: 61 nTPM
- neutrophil: 59 nTPM
- NK-cell: 57 nTPM
Brain region
- cerebellum: 29 nTPM
- white matter: 21 nTPM
- cerebral cortex: 21 nTPM
- thalamus: 20 nTPM
- hippocampal formation: 19 nTPM
- basal ganglia: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0.25
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of VCF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VCF1 as an antibody target. Whether an autoantibody or antibody against VCF1 could matter depends on whether native VCF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VCF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label VCF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...